1. Home
  2. XBIO vs HYFM Comparison

XBIO vs HYFM Comparison

Compare XBIO & HYFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xenetic Biosciences Inc.

XBIO

Xenetic Biosciences Inc.

HOLD

Current Price

$1.93

Market Cap

4.7M

Sector

Health Care

ML Signal

HOLD

Logo Hydrofarm Holdings Group Inc.

HYFM

Hydrofarm Holdings Group Inc.

BUY

Current Price

$0.74

Market Cap

4.5M

Sector

Industrials

ML Signal

BUY

Company Overview

Basic Information
Metric
XBIO
HYFM
Founded
N/A
1977
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.7M
4.5M
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
XBIO
HYFM
Price
$1.93
$0.74
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
22.2K
★ 70.0K
Earning Date
11-12-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 38.52
N/A
EPS
★ N/A
N/A
Revenue
$2,976,411.00
★ $134,252,000.00
Revenue This Year
$2.37
$54.93
Revenue Next Year
N/A
$5.31
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 19.04
N/A
52 Week Low
$1.85
$0.50
52 Week High
$4.94
$3.20

Technical Indicators

Market Signals
Indicator
XBIO
HYFM
Relative Strength Index (RSI) 32.29 38.38
Support Level N/A $0.50
Resistance Level $2.53 $1.04
Average True Range (ATR) 0.12 0.11
MACD 0.03 -0.01
Stochastic Oscillator 11.03 14.81

Price Performance

Historical Comparison
XBIO
HYFM

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immuno-oncology technologies addressing difficult-to-treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors. Its product pipeline consists of two key programs, XBIO-015 and XBIO-020, which are being developed to address pancreatic carcinoma and solid tumours.

About HYFM Hydrofarm Holdings Group Inc.

Hydrofarm Holdings Group Inc is an independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture (CEA), including grow lights, climate control solutions, grow media, nutrients, and other products. Hydroponics involves growing plants in soilless media, often using artificial lighting in controlled indoor or greenhouse environments. Its products are used to cultivate cannabis, flowers, fruits, vegetables, grains, and herbs, enabling control over key factors such as temperature, humidity, light, nutrients, and pH. Its product portfolio spans lighting, grow media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies. The United States generates maximum revenue.

Share on Social Networks: